Research findings from trial support the safety of supervised re-vaccination of the COVID-19 mRNA vaccine in patients who previously experienced an immediate allergic reaction.
Research findings published in The Journal of Allergy and Clinical Immunology support the safety of supervised re-vaccination of the COVID-19 mRNA vaccine in patients who previously experienced immediate allergic reaction after initial mRNA COVID-19 vaccine dose. Congratulations to Dr. Khalid on publishing this work!
See the abstract at this link.
